相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Efficient Presentation of Soluble Antigen by Cultured Human Dendritic Cells Is Maintained by Granulocyte/Macrophage Colony-stimulating Factor Plus Interleukin 4 and Downregulated by Tumor Necrosis Factor α
Federica Sallusto et al.
JOURNAL OF IMMUNOLOGY (2018)
TLR3-Mediated CD8+ Dendritic Cell Activation Is Coupled with Establishment of a Cell-Intrinsic Antiviral State
Lajos Szeles et al.
JOURNAL OF IMMUNOLOGY (2015)
Protective immunity against malaria after vaccination
J. B. de Souza
PARASITE IMMUNOLOGY (2014)
Tuberculosis vaccines - rethinking the current paradigm
Peter Andersen et al.
TRENDS IN IMMUNOLOGY (2014)
Dendritic cell-targeted vaccines - hope or hype?
Wolfgang Kastenmueller et al.
NATURE REVIEWS IMMUNOLOGY (2014)
B-lymphocyte tolerance and effector function in immunity and autoimmunity
Wasif N. Khan et al.
IMMUNOLOGIC RESEARCH (2013)
Multivalent glycopeptide dendrimers for the targeted delivery of antigens to dendritic cells
Juan J. Garcia-Vallejo et al.
MOLECULAR IMMUNOLOGY (2013)
The physiological role of DC-SIGN: A tale of mice and men
Juan J. Garcia-Vallejo et al.
TRENDS IN IMMUNOLOGY (2013)
Vaccine delivery using nanoparticles
Anthony E. Gregory et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2013)
How B cells capture, process and present antigens: a crucial role for cell polarity
Maria-Isabel Yuseff et al.
NATURE REVIEWS IMMUNOLOGY (2013)
Comparison of antibodies and carbohydrates to target vaccines to human dendritic cells via DC-SIGN
Luis J. Cruz et al.
BIOMATERIALS (2012)
The C-type lectin receptor CLEC9A mediates antigen uptake and (cross-)presentation by human blood BDCA3+ myeloid dendritic cells
Gerty Schreibelt et al.
BLOOD (2012)
Fcγ receptor antigen targeting potentiates cross-presentation by human blood and lymphoid tissue BDCA-3+ dendritic cells
Thijs W. H. Flinsenberg et al.
BLOOD (2012)
Glycan-modified liposomes boost CD4+ and CD8+ T-cell responses by targeting DC-SIGN on dendritic cells
Wendy W. J. Unger et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Skin Langerin+ Dendritic Cells Transport Intradermally Injected Anti-DEC-205 Antibodies but Are Not Essential for Subsequent Cytotoxic CD8+ T Cell Responses
Vincent Flacher et al.
JOURNAL OF IMMUNOLOGY (2012)
Antibody responses initiated by Clec9A-bearing dendritic cells in normal and Batf3-/- mice
Irina Caminschi et al.
MOLECULAR IMMUNOLOGY (2012)
Boosting antibody responses by targeting antigens to dendritic cells
Irina Caminschi et al.
TRENDS IN IMMUNOLOGY (2012)
CD205 antigen targeting combined with dendritic cell recruitment factors and antigen-linked CD40L activation primes and expands significant antigen-specific antibody and CD4+ T cell responses following DNA vaccination of outbred animals
Leo M. Njongmeta et al.
VACCINE (2012)
Cancer immunotherapy via dendritic cells
Karolina Palucka et al.
NATURE REVIEWS CANCER (2012)
Antitumor activity of liposomal ErbB2/HER2 epitope peptide-based vaccine constructs incorporating TLR agonists and mannose receptor targeting
Jean-Sebastien Thomann et al.
BIOMATERIALS (2011)
Targeted delivery of TLR ligands to human and mouse dendritic cells strongly enhances adjuvanticity
Paul J. Tacken et al.
BLOOD (2011)
Potent Antitumor Immunity Generated by a CD40-Targeted Adenoviral Vaccine
Basav N. Hangalapura et al.
CANCER RESEARCH (2011)
Lewis X oligosaccharides-heparanase complex targeting to DCs enhance antitumor response in mice
Hongjie Chen et al.
CELLULAR IMMUNOLOGY (2011)
Route of Administration Modulates the Induction of Dendritic Cell Vaccine-Induced Antigen-Specific T Cells in Advanced Melanoma Patients
W. Joost Lesterhuis et al.
CLINICAL CANCER RESEARCH (2011)
Design of neo-glycoconjugates that target the mannose receptor and enhance TLR-independent cross-presentation and Th1 polarization
Satwinder Kaur Singh et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
Protective T cell immunity in mice following protein-TLR7/8 agonist-conjugate immunization requires aggregation, type I IFN, and multiple DC subsets
Kathrin Kastenmueller et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Targeting Antigen to Mouse Dendritic Cells via Clec9A Induces Potent CD4 T Cell Responses Biased toward a Follicular Helper Phenotype
Mireille H. Lahoud et al.
JOURNAL OF IMMUNOLOGY (2011)
Targeting Nanosystems to Human DCs via Fc Receptor as an Effective Strategy to Deliver Antigen for Immunotherapy
Luis J. Cruz et al.
MOLECULAR PHARMACEUTICS (2011)
Dendritic Cell Based Tumor Vaccination in Prostate and Renal Cell Cancer: A Systematic Review and Meta-Analysis
Andreas Draube et al.
PLOS ONE (2011)
Activation of Antigen-Specific T Cell-Responses by Mannan-Decorated PLGA Nanoparticles
Samar Hamdy et al.
PHARMACEUTICAL RESEARCH (2011)
Targeting human dendritic cell subsets for improved vaccines
Hideki Ueno et al.
SEMINARS IN IMMUNOLOGY (2011)
Harnessing human dendritic cell subsets for medicine
Hideki Ueno et al.
IMMUNOLOGICAL REVIEWS (2010)
Targeted PLGA nano- but not microparticles specifically deliver antigen to human dendritic cells via DC-SIGN in vitro
Luis J. Cruz et al.
JOURNAL OF CONTROLLED RELEASE (2010)
Harnessing Dendritic Cells to Generate Cancer Vaccines
Karolina Palucka et al.
CANCER VACCINES (2009)
Innate signaling by the C-type lectin DC-SIGN dictates immune responses
Jeroen den Dunnen et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Improving vaccines by targeting antigens to dendritic cells
Ken Shortman et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2009)
Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation
Satwinder Kaur Singh et al.
MOLECULAR IMMUNOLOGY (2009)
Identification of a dendritic cell receptor that couples sensing of necrosis to immunity
David Sancho et al.
NATURE (2009)
CD11c provides an effective immunotarget for the generation of both CD4 and CD8 T cell responses
Fernanda V. V. Castro et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
Circumvention of regulatory CD4+ T cell activity during cross-priming strongly enhances T cell-mediated immunity
Antje Heit et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
Tumor therapy in mice via antigen targeting to a novel, DC-restricted C-type lectin
David Sancho et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Engineered lentivector targeting of dendritic cells for in vivo immunization
Lili Yang et al.
NATURE BIOTECHNOLOGY (2008)
Homeostatic and maturation-associated proliferation in the peripheral B-cell compartment
Menno C. van Zelm et al.
CELL CYCLE (2007)
Putative IKDCs are functionally and developmentally similar to natural killer cells, but not to dendritic cells
Irina Caminschi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
A toll-like receptor-2-directed fusion protein vaccine against tuberculosis
Baolin Wang et al.
CLINICAL AND VACCINE IMMUNOLOGY (2007)
Dendritic cells prime natural killer cells by trans-presenting interleukin 15
Mathias Lucas et al.
IMMUNITY (2007)
DEC-205 receptor on dendritic cells mediates presentation of HIV gag protein to CD8+ T cells in a spectrum of human MHC I haplotypes
Leonia Bozzacco et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Vaccination with recombinant fusion proteins incorporating Toll-like receptor ligands induces rapid cellular and humoral immunity
James W. Huleatt et al.
VACCINE (2007)
Toll-dependent selection of microbial antigens for presentation by dendritic cells
JM Blander et al.
NATURE (2006)
Intensified and protective CD4+ T cell immunity in mice with anti-dendritic cell HIV gag fusion antibody vaccine
C Trumpfheller et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Antigen targeting to dendritic cells elicits long-lived T cell help for antibody responses
SB Boscardin et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Interferon-producing killer dendritic cells provide a link between innate and adaptive immunity
CW Chan et al.
NATURE MEDICINE (2006)
Targeting antigens to dendritic cells in vivo
Paul J. Tacken et al.
IMMUNOBIOLOGY (2006)
HIV Gag protein conjugated to a toll-like receptor 7/8 agonist improves the magnitude and quality of Th1 and CD8+ T cell responses in nonhuman primates
U Wille-Reece et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Antigen delivery via two molecules on the CD8- dendritic cell subset induces humoral immunity in the absence of conventional danger
AJ Corbett et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2005)
Effective induction of naive and recall T-cell responses by targeting antigen to human dendritic cells via a humanized anti-DC-SIGN antibody
PJ Tacken et al.
BLOOD (2005)
The beta2 integrin CDIIc distinguishes a subset of cytotoxic pulmonary T cells with potent antiviral effects in vitro and in vivo
M Beyer et al.
RESPIRATORY RESEARCH (2005)
Immunization with HIV-1 Gag protein conjugated to a TLR7/8 agonist results in the generation of HIV-1 Gag-specific Th1 and CD8+ T cell responses
U Wille-Reece et al.
JOURNAL OF IMMUNOLOGY (2005)
Peptides chaperoned by heat-shock proteins are a necessary and sufficient source of antigen in the cross-priming of CD8+ T cells
RJ Binder et al.
NATURE IMMUNOLOGY (2005)
Inflammatory mediators are insufficient for full dendritic cell activation and promote expansion of CD4+ T cell populations lacking helper function
R Spörri et al.
NATURE IMMUNOLOGY (2005)
DC-SIGN promotes exogenous MHC-I-restricted HIV-1 antigen presentation
A Moris et al.
BLOOD (2004)
Mannose receptor targeting of tumor antigen pmel17 to human dendritic cells directs anti-melanoma T cell responses via multiple HLA molecules
V Ramakrishna et al.
JOURNAL OF IMMUNOLOGY (2004)
A totally synthetic vaccine of generic structure that targets Toll-like receptor 2 on dendritic cells and promotes antibody or cytotoxic T cell responses
DC Jackson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Liposomal meningococcal B vaccination: Role of dendritic cell targeting in the development of a protective immune response
C Arigita et al.
INFECTION AND IMMUNITY (2003)
CD40-targeted adenoviral gene transfer to dendritic cells through the use of a novel bispecific single-chain Fv antibody enhances cytotoxic T cell activation
JG Brandao et al.
VACCINE (2003)
The use of dendritic cells in cancer immunotherapy
G Schuler et al.
CURRENT OPINION IN IMMUNOLOGY (2003)
Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance
L Bonifaz et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Immunostimulatory DNA-based vaccines elicit multifaceted immune responses against HIV at systemic and mucosal sites
AA Horner et al.
JOURNAL OF IMMUNOLOGY (2001)
B1 cells: similarities and differences with other B cell subsets
F Martin et al.
CURRENT OPINION IN IMMUNOLOGY (2001)
CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin
S Basu et al.
IMMUNITY (2001)
Exogenous antigen targeted to FcγRI on myeloid cells is presented in association with MHC class I
PK Wallace et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2001)
Conjugation of immunostimulatory DNA to the short ragweed allergen Amb a 1 enhances its immunogenicity and reduces its allergenicity
H Tighe et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2000)
Immunostimulatory DNA-based vaccines induce cytotoxic lymphocyte activity by a T-helper cell-independent mechanism
HJ Cho et al.
NATURE BIOTECHNOLOGY (2000)
Germinal centers without T cells
CG de Vinuesa et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Rapid antibody responses by low-dose, single-step, dendritic cell-targeted immunization
H Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
分享论文
